Designing a Tri-Peptide based HIV-1 protease inhibitor Presented by, Sushil Kumar Singh IBAB,Bangalore Submitted to Dr. Indira Ghosh AstraZeneca India Research Center, Bangalore - PowerPoint PPT Presentation

About This Presentation
Title:

Designing a Tri-Peptide based HIV-1 protease inhibitor Presented by, Sushil Kumar Singh IBAB,Bangalore Submitted to Dr. Indira Ghosh AstraZeneca India Research Center, Bangalore

Description:

Designing a Tri-Peptide based HIV-1 protease inhibitor Presented by, Sushil Kumar Singh IBAB,Bangalore Submitted to Dr. Indira Ghosh AstraZeneca India Research Center ... – PowerPoint PPT presentation

Number of Views:153
Avg rating:3.0/5.0

less

Transcript and Presenter's Notes

Title: Designing a Tri-Peptide based HIV-1 protease inhibitor Presented by, Sushil Kumar Singh IBAB,Bangalore Submitted to Dr. Indira Ghosh AstraZeneca India Research Center, Bangalore


1
Designing a Tri-Peptide based HIV-1 protease
inhibitorPresented by, Sushil Kumar
SinghIBAB,BangaloreSubmitted to Dr. Indira
GhoshAstraZeneca India Research Center, Bangalore
2
Objective
  • The objective of my project was to come up with a
    certain number of lead molecules which can be
    potential HIV1 Protease inhibitors.
  • Based on the assignments I have tried to come up
    with different ways of designing drug molecules
    for the same target.
  • In the end I expected to have a library of
    molecules having a high possibility of activity
    against the target.
  • This information is vital for the future of
    rational drug designing, leading to more
    effective drugs with minimal side effects.

3
Flowchart of the path taken for the project
4
Protocol
  • Built the model using Homology from InsightII.
  • Analog-Based Drug Designing
  • Used Analog Builder to generate both product and
    reagent based libraries using a scaffold from
    published literature.
  • The library was annotated using the ' Lipinski's
    Rule of Five '.
  • The resulting compounds were tested for docking
    score using Ligand-Fit and then their activity
    was predicted using Hypogen as well as QSAR.
  • Structure-Based Drug Design
  • Structure of active site of receptor were
    analysed and analog were generated ,but
    unfortunately we got some negative score.

5
Pharmacophore-Based Drug Design
  • This was achieved using 3 different methods
  • 1.A pharmacophore was built based on the
    structure of receptor.
  • 2.Pharmacophore based on the common feature of
    known drugs.
  • (Hip-Hop)
  • 3.Based on the activity of the known potential
    hiv protease inhibitors (training set of data)-
    Hypo-gen
  • - Using the best hypothesis from Hip-Hop the
    generated compounds were analysed.
  • - The best hypothesis resulting from Hypo-gen was
    used to predict the activity of the lead
    molecule.
  • QSAR Activity prediction - The activity of the
    lead compounds generated earlier was predicted
    using QSAR.

6
Analysis
  • The analog library which was generated, many of
    the compounds were not following the ' Lipinski's
    Rule of 5'. On analysis I found that the
    fragments which I selected for library building
    were of high mol wt, more no. of HB
    donor/acceptor and in some cases no. of
    rotatable bonds were also more. To avoid this I
    generated library using fragments with low mol
    wt. And less no. of rotatable bonds.
  • Hypothesis generation
  • For a hypothesis to be good
  • - the range between Fixed cost and Null cost
    should be high.
  • ( F.c- N.c gt 85 )
  • - the total cost should be closer to the fixed
    cost.
  • - The Config. Cost factor should be less than 17.

7
Hypothesis Analysis
  • I faced difficulty in deciding which hypothesis
    to take out of 10. Because many of the hypothesis
    were showing same type of variations with their
    values.
  • To come out with the best hypothesis I did
    clustering, that also didn't give good result as
    most of the hypothesis were of same nature.
  • Then we analysed the training set of data, which
    we used for hypothesis generation and found that
    most of the fragment were of common character,
    which might be the reason for not getting much
    variation.
  • To proceed further, we took one hypothesis, but
    we couldn't validate our result using this
    hypothesis as it is not following the criteria of
    config and costs.

8
Score comparision
  • Null Hypothesis dumping score for the null
    hypothesis
  • Total cost57.9634 RMS1.7127 correl0Cost
    components Error57.9634 Weight0 Config0
    Mapping0 Tolerance 0
  • Hypothesis Taken
  • Total cost64.0193 RMS0.634962
    correl0.937511Cost components Error42.7823
    Weight1.58709 Config19.6499 Tolerance0
  • Fixed CostTotal cost61.1381 RMS0 correl0
    Cost components Error40.3633 Weight1.12491
    Config19.6499 Tolerance0

9
Activity (Ic 50)
10
QSAR
  • Molecules for the training set of data were
    generated into catalyst and imported to Cerius2.
    They were added to the study-table.
  • Descriptors taken
  • Topological descriptors
  • Hosoya index, Zagreb index, Chi index,
    Winner index etc.
  • Fragments constant descriptors
  • HB acceptors, HB donor etc.
  • Charge desriptors
  • Charge, dipole Apo l etc.
  • Every descriptor adds a dimension to the chemical
    space, to reduce the dimensionality without
    loosing any information we did PCA ( Principal
    Component Analysis).
  • Using GFA we predicted the activities of the
    compound which we generated.

11
QSAR analysis
  • By QSAR analysis I tried to find contribution of
    active fragments in the activity of the compound.
  • While analysing the QSAR equations I found many
    terms with negative sign which were not good for
    the activity, so I substituted the groups to
    nullify the effect.
  • By making the substitution I noticed that
    activity of the compound is changing.
  • e.g
  • If we replace ester group by an amide group we
    found activity increased by 300 fold.
  • On introducing HB donor or acceptor, the
    activity of the compound decreased as we found
    that replacement of methyl group with hydroxyl
    group led to 2500 times lower activity.

12
Conclusion
13
(No Transcript)
14
(No Transcript)
15
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com